tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Debjit Chattopadhyay, 185 are a BUY (91.58%), 17 are a HOLD (8.42%).
Analyst Debjit Chattopadhyay, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 50.12% that have a potential upside of 35.13% achieved within 287 days.
Debjit Chattopadhyay’s has documented 414 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RARE, Ultragenyx at 05-Jan-2026.
Analyst best performing recommendations are on HARP (HARPOON THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $22 was fulfilled within 1 day with a profit of $3.15 (12.52%) receiving and performance score of 125.25.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 01-Apr-2025
$53
$30.16 (132.05%)
$53
1 months 17 days ago
(04-Dec-2025)
6/9 (66.67%)
$27.52 (108.01%)
102
Buy
Since 25-Sep-2025
$60
$37.16 (162.70%)
$80
2 months 9 days ago
(12-Nov-2025)
3/5 (60%)
$29.88 (99.20%)
116
Buy
Since 10-May-2023
$45
$22.16 (97.02%)
$24
2 months 17 days ago
(04-Nov-2025)
7/8 (87.5%)
$10.71 (31.23%)
443
Hold
Since 29-Feb-2024
$38
$15.16 (66.37%)
$56
2 months 17 days ago
(04-Nov-2025)
7/9 (77.78%)
$3.71 (10.82%)
263
Buy
Since 25-Sep-2025
$60
$37.16 (162.70%)
$20
3 months 27 days ago
(25-Sep-2025)
5/5 (100%)
$7.35 (13.96%)
138
Which stock is Debjit Chattopadhyay is most bullish on?
Which stock is Debjit Chattopadhyay is most reserved on?
What Year was the first public recommendation made by Debjit Chattopadhyay?
